Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02216838
PHASE4

Treatment of Facial Flushing With Botulinum Toxin A Injections

Sponsor: Northwestern University

View on ClinicalTrials.gov

Summary

The purpose of this study is to find out if botulinum toxin A (botox®) can be used to treat facial flushing. This study is a pilot study designed to determine feasibility of these procedures.

Official title: Treatment of Facial Flushing With Botulinum Toxin A Injections: A Split-Face, Double-blinded, Randomized Control Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2014-08

Completion Date

2025-12

Last Updated

2025-01-31

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

botulinum toxin A

A total of 10U will be injected at 1cm increments by the blinded dermatologist into the respective randomized side.

OTHER

Saline Control

A total of 0.5cc benzyl alcohol containing saline will be injected at 1cm increments by the blinded dermatologist into the respective randomized side

Locations (1)

Northwestern University Feinberg School of Medicine, Department of Dermatology

Chicago, Illinois, United States